Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Dumpit

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Journal of Urology|January 18, 2018
Prostate Cancer Disseminated Tumor Cells are Rarely Detected in the Bone Marrow of Patients with Localized Disease Undergoing Radical Prostatectomy across Multiple Rare Cell Detection PlatformsHeather J Chalfin, Stephanie A Glavaris, Paymaneh D Malihi, et al.
The Journal of Clinical Investigation|September 16, 2025
Multiomic assessments of LNCaP and derived cell strains reveal determinants of prostate cancer pathobiologyArnab Bose, Armand Bankhead, Ilsa Coleman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 26, 2013
Prostate cancer cell phenotypes based on AGR2 and CD10 expressionMelissa E Ho, Sue-Ing Quek, Lawrence D True, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2015
SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate CancerXiaotun Zhang, Ilsa M Coleman, Lisha G Brown, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategiesSander Frank, Thomas Persse, Ilsa Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2018
Contribution of Adrenal Glands to Intratumor Androgens and Growth of Castration-Resistant Prostate CancerElahe A Mostaghel, Ailin Zhang, Susana Hernandez, et al.
Cancer Research Communications|November 7, 2022
Comprehensive assessment of anaplastic lymphoma kinase in localized and metastatic prostate cancer reveals targetable alterationsRadhika A Patel, Ilsa Coleman, Martine P Roudier, et al.
Prostate Cancer and Prostatic Diseases|December 23, 2022
Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancerMichael T Schweizer, Roman Gulati, Todd Yezefski, et al.
The Journal of Clinical Investigation|September 19, 2023
Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer modelsSupreet Agarwal, Lei Fang, Kerry McGowen, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Deep learning-based non-invasive profiling of tumor transcriptomes from cell-free DNA for precision oncologyRobert D Patton, Alexander Netzley, Thomas W Persse, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Urology|January 18, 2018
Prostate Cancer Disseminated Tumor Cells are Rarely Detected in the Bone Marrow of Patients with Localized Disease Undergoing Radical Prostatectomy across Multiple Rare Cell Detection PlatformsHeather J Chalfin, Stephanie A Glavaris, Paymaneh D Malihi, et al.
The Journal of Clinical Investigation|September 16, 2025
Multiomic assessments of LNCaP and derived cell strains reveal determinants of prostate cancer pathobiologyArnab Bose, Armand Bankhead, Ilsa Coleman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 26, 2013
Prostate cancer cell phenotypes based on AGR2 and CD10 expressionMelissa E Ho, Sue-Ing Quek, Lawrence D True, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2015
SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate CancerXiaotun Zhang, Ilsa M Coleman, Lisha G Brown, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategiesSander Frank, Thomas Persse, Ilsa Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2018
Contribution of Adrenal Glands to Intratumor Androgens and Growth of Castration-Resistant Prostate CancerElahe A Mostaghel, Ailin Zhang, Susana Hernandez, et al.
Cancer Research Communications|November 7, 2022
Comprehensive assessment of anaplastic lymphoma kinase in localized and metastatic prostate cancer reveals targetable alterationsRadhika A Patel, Ilsa Coleman, Martine P Roudier, et al.
Prostate Cancer and Prostatic Diseases|December 23, 2022
Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancerMichael T Schweizer, Roman Gulati, Todd Yezefski, et al.
The Journal of Clinical Investigation|September 19, 2023
Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer modelsSupreet Agarwal, Lei Fang, Kerry McGowen, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Deep learning-based non-invasive profiling of tumor transcriptomes from cell-free DNA for precision oncologyRobert D Patton, Alexander Netzley, Thomas W Persse, et al.
Pageof 3